TGFB1 and atherosclerosis: We compared the level of physiological TGF-β1 activation during blood clotting in patients and control individuals, and examined whether TGF-β1 activation was associated with clinical phenotype, in particular inflammatory disease activity, cumulative organ damage and early atherosclerosis.